Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
---|
02/22/2007 | WO2007022366A2 Rosuvastatin calcium with a low salt by-product content |
02/22/2007 | WO2007021858A2 Methods of making radiolabeled tracers and precursors thereof |
02/22/2007 | WO2007020411A1 Amide derivatives |
02/22/2007 | WO2007020194A1 Piperidine and piperazine derivatives as p2x3 antagonists |
02/22/2007 | WO2007020046A1 Benzoquinazoline derivatives and their use in treating bone disorders |
02/22/2007 | WO2006135763A3 Inhibitors of dna repair enzymes and methods of use thereof |
02/22/2007 | WO2006108695A3 Sulfoximine-pyrimidine macrocycles and the salts thereof , a process for making them, and their pharmaceutical use against cancer |
02/22/2007 | WO2006097617B1 Novel dihydropyrimidine derivatives and their use as anti-cancer agents |
02/22/2007 | WO2005089511A3 Novel pharmaceutical forms, and methods of making and using the same |
02/22/2007 | US20070043065 Amide derivatives |
02/22/2007 | US20070043048 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents |
02/22/2007 | US20070043037 Pyrimidine derivatives as orexin receptor antagonists |
02/22/2007 | US20070042996 N-alkynyl-2-(substituted aryloxy) alkylthioamine derivatives as fungicides |
02/22/2007 | US20070042935 Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having parp enzyme inhibitory effect |
02/22/2007 | US20070042908 Herbicide composition |
02/22/2007 | CA2619867A1 Rosuvastatin calcium with a low salt by-product content |
02/22/2007 | CA2619249A1 Benzoquinazoline derivatives and their use in treating bone disorders |
02/22/2007 | CA2618988A1 Methods of making radiolabeled tracers and precursors thereof |
02/22/2007 | CA2618451A1 Amide derivatives |
02/22/2007 | CA2618340A1 Piperidine and piperazine derivatives as p2x3 antagonists |
02/21/2007 | EP1754710A2 2'-Fluoroncucleosides |
02/21/2007 | EP1754703A2 N-Heterocyclic derivatives as nos inhibitors |
02/21/2007 | EP1754700A2 Synthesis of oligoketides |
02/21/2007 | EP1754475A1 Use of C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
02/21/2007 | EP1753735A1 Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators |
02/21/2007 | EP1753731A2 Pyrimidin-4-one derivatives and their use as p38 kinase modulators |
02/21/2007 | EP1753713A2 Synthesis of tetracyclines and analogues thereof |
02/21/2007 | EP1753429A1 Modulators of muscarinic receptors |
02/21/2007 | EP1551797B1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
02/21/2007 | EP1501508B1 Inhibitors of histone deacetylase |
02/21/2007 | EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
02/21/2007 | EP0968193B1 Phenylsulphonyl ureas, processes for their preparation and their use as herbicides and plant-growth regulators |
02/21/2007 | CN1918134A Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cyto kine inhibitors |
02/21/2007 | CN1918133A Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases |
02/21/2007 | CN1918128A Fused ring 4-oxopyrimidine derivative |
02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
02/21/2007 | CN1917921A Calcitonin gene related peptide receptor antagonists |
02/21/2007 | CN1917881A Novel phenylalanine derivatives |
02/21/2007 | CN1917880A Pyrimidines with tie2 (tek) activity |
02/21/2007 | CN1917879A Pyrimidines with tie2 (tek) activity |
02/21/2007 | CN1916009A Process for preparing amine platinum complexes |
02/20/2007 | US7179916 Process for the preparation of rosuvastatin |
02/20/2007 | US7179914 reacting formamide with formyl methyl alkyl ketone diacetal; distilaltion |
02/20/2007 | US7179912 Materials and methods to potentiate cancer treatment |
02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
02/20/2007 | US7179816 Chemical derivatives and their application as antitelomerase agents |
02/20/2007 | US7179815 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
02/20/2007 | US7179806 Δ1-pyrrolines used as pesticides |
02/20/2007 | US7179493 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
02/20/2007 | US7179307 Oxidative hair dyes containing plant extracts |
02/20/2007 | CA2263561C Thienopyrimidines |
02/20/2007 | CA2186784C The use of carboxylic acid derivatives as drugs |
02/15/2007 | WO2007019083A1 Pyrimidine compounds as serotonin receptor modulators |
02/15/2007 | WO2007018325A1 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof |
02/15/2007 | WO2007018248A1 Pyridone compound |
02/15/2007 | WO2007017117A1 Process for the synthesis of rosuvastatin calcium |
02/15/2007 | WO2007017114A1 New substituted azathymidine derivatives and their use in the treatment of bacterial infectious diseases |
02/15/2007 | WO2007017093A1 Substituted 2-benzyloxy-benzoic acid amide derivatives |
02/15/2007 | WO2006133242A3 Azinone and diazinone v3 inhibitors for depression and stress disorders |
02/15/2007 | WO2006081337A3 Erastin analogues and their uses for killing cancer cells |
02/15/2007 | WO2006079504A3 Process for the manufacture of a precursor of vitamin b1 |
02/15/2007 | WO2005123703A8 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
02/15/2007 | US20070037979 Preparation of rosuvastatin |
02/15/2007 | US20070037838 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[2,3d 6,5-d']dipyrimidyne and 10-aza-analogue thereof |
02/15/2007 | US20070037836 Melanin concentrating hormone; obesity and related disorders, anxiety, or depression; trans-4-Bromo-N-{4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-2-trifluoromethoxy-benzenesulfonamide |
02/15/2007 | US20070037822 Azinone and diazinone V3 inhibitors for depression and stress disorders |
02/15/2007 | US20070037812 Such as 3-{4-[3-(4-Chloro-2- phenoxy-phenoxy)- phenoxy]-2-methyl- phenyl}-propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis |
02/15/2007 | US20070037234 Fluorogenic enzyme substrates and methods of preparation |
02/15/2007 | CA2618112A1 Pyridone compound |
02/15/2007 | CA2617760A1 Pyrimidine compounds as serotonin receptor modulators |
02/14/2007 | EP1751118A1 Pyrimidines for use as plk inhibitors |
02/14/2007 | EP1751117A2 Process for the preparation of aminopyrimidines |
02/14/2007 | EP1751116A2 Pyrimidine compounds and use thereof |
02/14/2007 | EP1751115A1 Theramutein modulators |
02/14/2007 | EP1750706A1 Dual small molecule inhibitors of cancer and angiogenesis |
02/14/2007 | EP1750510A1 Difluoromethanesulfonyl anilide derivatives useful as herbicides |
02/14/2007 | EP1603876B1 Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto esters |
02/14/2007 | EP1533292B1 Dibenzylamine compound and medicinal use thereof |
02/14/2007 | EP1532121B1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives |
02/14/2007 | EP0999256B1 Compounds for organic el element and organic el element |
02/14/2007 | CN1914208A Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalklymine]-pyrimido[1,2a]pyrimidin-6-one derivatives |
02/14/2007 | CN1914182A 喹唑啉衍生物 Quinazoline derivatives |
02/14/2007 | CN1913886A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors |
02/14/2007 | CN1913880A Method for treating ADAMTS-5-associated disease |
02/14/2007 | CN1300118C Preparation method of 4-(3-chlor-4-fluorobenzeneamidocyanogen)-7-methoxy-6-(3-morpholine oxypropyl)quinazoline |
02/13/2007 | US7176312 Kinase inhibitor scaffolds and methods for their preparation |
02/13/2007 | US7176310 Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents |
02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
02/13/2007 | US7176212 2,4-diamino pyrimidine compounds having anti-cell proliferative activity |
02/13/2007 | US7176211 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
02/13/2007 | US7176210 Cannabinoid receptor ligands and uses thereof |
02/13/2007 | US7176199 Useful as a preventive or/and a therapeutic agent for a disease in which alpha v beta 3 integrin is involved |
02/13/2007 | CA2463976C N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
02/13/2007 | CA2122236C Quinolines and their analogs |
02/13/2007 | CA2112420C N-arylhydrazine derivatives as insecticidal and acaricidal agents |
02/08/2007 | WO2007016355A2 Process for the synthesis of progesterone receptor modulators |
02/08/2007 | WO2007016286A1 Synthesis of 4/5-pyrimidinylimidazoles via sequential functionalization of 2,4-dichloropyrimidine |
02/08/2007 | WO2007014607A1 Quadratic acid derivatives in the form of a protein kinase inhibitors |
02/08/2007 | WO2006023843A3 Novel heterocycles |
02/08/2007 | US20070032514 2,4-diamino-pyrimidines as aurora inhibitors |